Fly News Breaks for March 20, 2017
Mar 20, 2017 | 07:07 EDT
SunTrust analyst Sandy Draper identifies PRA Health as his favorite late-stage contract research organization, or CRO. The analyst expects the company's partnerships to drive double digit percentage revenue growth through at least 2018. Draper says that the company has high quality bookings, and he raised his price target on the shares to $72 from $70. He keeps a Buy rating on the stock.
News For PRAH From the Last 2 Days